J Korean Diabetes.  2018 Mar;19(1):1-6. 10.4093/jkd.2018.19.1.1.

K-Sunshine Act: Submission of an Expense Report on Details of Economic Interest

• Lee I

• KMID: 2408651
• DOI: http://doi.org/10.4093/jkd.2018.19.1.1

Abstract

(1) A drug provider shall prepare an expense report on economic interests, etc. to be provided to pharmacists, oriental medicine pharmacists, medical personnel, medical institution founders, or persons working for a medical institution, within three months after the termination of each fiscal year, as prescribed by Ordinance of the Ministry of Health and Wealth, and shall retain the relevant expense report, books related thereto, and base data for five years. (2) Where deemed necessary, the Minister of Health and Wealth may request the submission of the expense report, books related thereto, and base data under paragraph (1). In such cases, a drug provider shall comply therewith without justifiable grounds.

Keyword

An expense report on economic interests; K-Sunshine Act

MeSH Terms

Clergy
Humans
Medicine, East Asian Traditional
Pharmacists

Reference

References

1. Kang HC. Overseas legal systems to enhance transparency in healthcare industries and those implications in South Korea-focusing the United States' Sunshine Act and Japanese Transparency Guideline-. Beopjo. 2013; 679:1382. Kang HC. Overseas legal systems to enhance transparency in healthcare industries and those implications in South Korea-focusing the United States' Sunshine Act and Japanese Transparency Guideline-. Beopjo 2013;679: 134–5.